TITLE

A pilot trial for comparison of photodynamic therapy and transpupillary thermotherapy for the management of classic subfoveal choroidal neovascularization secondary to age-related macular degeneration

AUTHOR(S)
Tewari, Hem K.; Prakash, Gaurav; Azad, Raj V.; Talwar, Dinesh; Kai, Sanjay
PUB. DATE
July 2007
SOURCE
Indian Journal of Ophthalmology;Jul2007, Vol. 55 Issue 4, p277
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Aim: The aim of the study was to compare the visual outcomes of photodynamic therapy (PDT) with verteporfin and transpupillary thermotherapy (TTT) for classic subfoveal choroidal neovascularization (CNVM) secondary to age-related macular degeneration (ARMD).Settings and Design: Patients with subfoveal classic CNVM caused by ARMD attending vitreo-retinal services at a tertiary care setup were included in this nonrandomized, open label, prospective, clinical, comparative pilot trial.Materials and Methods: Standardized refraction, visual acuity testing, evaluation of fundus and serial color photography and fundus fluorescein angiography were carried out to evaluate the effects of treatment in 32 eyes each undergoing either PDT or TTT. Follow-up was carried out at four weeks, 12 weeks and six months. Retreatment if indicated was carried out three months post treatment.Results: Stabilization or improvement occurred in 69% of patients undergoing PDT and 50% patients undergoing TTT at six months of follow-up. Among patients with a pretreatment visual acuity greater than or equal to 20/63, only one out of six patients who underwent PDT had a drop of visual acuity > 2 lines as compared to four patients (100%) who underwent TTT. (P =0.0476, two-tailed Fisher's exact test).Conclusion: For short-term preservation of vision in patients of classic CNVM due to ARMD, PDT seems to be better than TTT if the pre-laser best corrected visual acuity is > 20/63 but both are equally effective if pre-laser best corrected visual acuity is < 20/63.
ACCESSION #
25561915

 

Related Articles

  • Transpupillary thermotherapy may help CNV patients. Charters, Lynda // Ophthalmology Times;09/15/99, Vol. 24 Issue 18, p33 

    Discusses the benefits of transpupillary thermotherapy for patients with occult subfoveal choroidal neovascularization secondary to age-related macular degeneration. Investigation of other approaches in therapy for ocular pathology; Testing of the effectiveness of transpupillary thermotherapy;...

  • PUTTING TTT IN CONTEXT.  // Review of Ophthalmology;Aug2005 part 2 of 2, Vol. 12, p9 

    Discusses the therapeutic role of transpupillary thermotherapy (TTT) in photodynamic therapy for age-related macular degeneration. Information on the treatment choice of several ophthalmologists; Overview of treatment parameters of TTT; Discussion on the financial burden of photodynamic...

  • Lasers in Photodynamic Therapy With Verteporfin for the Treatment of Age-Related Macular Degeneration.  // Review of Ophthalmology;May2000, Vol. 7 Issue 5, p51 

    Describes the principles, treatment parameters and indications for laser photodynamic therapy with verteporfin in the United States. Treatment of age-related macular degeneration in patients with classic subfoveal choroidal neovascular; Comparison of photocoagulation and photodynamic therapy;...

  • Studies to determine if others may benefit from PDT. Talsma, Julia // Ophthalmology Times;2/15/2002, Vol. 27 Issue 4, p10 

    Highlights several clinical trials aimed at expanding the benefits of photodynamic therapy (PDT) for patients with subfoveal choroidal neovascularization (CNV) in age-related macular degeneration. Results of the PDT with verteporfin trial; Rationale of the Visudyne In Minimally Classic CNV...

  • Treatment Options.  // Ophthalmology Times;1/15/2005 Supplement, Vol. 30, p6 

    The article presents information about methods for treating age-related macular degeneration. According to the treatment of age-related macular degeneration with photodynamic therapy and verteporfin in photodynamic therapy reports, subfoveal classic or predominantly classic CNV should be treated...

  • New Approaches to Age-Related Macular Degeneration.  // Review of Ophthalmology;Sep2000, Vol. 7 Issue 9, p101 

    Focuses on developments in treating age-related macular degeneration. Laser treatment available; Prophylactic use of laser photocoagulation; Transpupillary thermotherapy; High-speed indocyanine green choroidal angiography; Photodynamic therapy.

  • When to Refer for PDT. Ajamian, Paul C. // Review of Optometry;06/15/2000, Vol. 137 Issue 6, p108 

    Answers questions regarding photodynamic therapy (PDT) in Indiana. Considerations in the referral of a macular degeneration patient for a PDT; Role of co-managing optometrists in referring patients for PDT; Benefits of PDT for wet age-related macular degeneration and subfoveal choroidal...

  • Which Treatment is Best for which AMD Patient? Kroll, P.; Meyer, C. H. // British Journal of Ophthalmology;Feb2006, Vol. 90 Issue 2, p128 

    The article focuses on the different treatment approaches for vascular age related macular degeneration. Transpupillary thermotherapy is a subthreshold photocoagulation delivering moderate heat to the choroid and retinal pigment epithelium using a diode laser. Photodynamic therapy using a...

  • PDT safe choice for eyes with predominantly classic CNV. Guttman, Cheryl; Kaiser, Peter K. // Ophthalmology Times;8/1/2003, Vol. 28 Issue 15, p25 

    Evaluates the safety of photo-dynamic therapy (PDT) using verteporfin for eyes with predominantly classic subfoveal choroidal neovascularization (CNV). Treatment of age-related macular degeneration; Benefits from verteporfin PDT treatment; Mean number of treatments administered among the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics